Galapagos changed course earlier this year, announcing it no longer wanted to focus on cell therapy and would seek buyers for this business. After shopping around the assets for months, Galapagos ...

Galapagos believed so strongly in its work developing new cancer cell therapies that it pinned its future on them. This past winter, the Belgian drugmaker unveiled a plan to spin out the rest of the ...

Galapagos is planning to wind down its cell therapy business, completing a whiplash change that saw the biotech go from focusing on the modality to ditching it in six months. Belgium-based Galapagos ...

Intention follows comprehensive strategic review process and would represent the optimal capital allocation pathway to support a stronger and sustainable future for Galapagos Mechelen, Belgium; ...

Galapagos (GLPG) announced that the works council consultation process regarding the wind-down of cell therapy activities has been completed and its board of directors has decided to initiate the wind ...

Galapagos ( (GLPG)) has issued an announcement. On January 5, 2026, Galapagos NV announced that, following completion of required works council consultations in Belgium and the Netherlands, its board ...